ppGalNAc T1 as a Potential Novel Marker for Human Bladder Cancer |
Ding, Ming-Xia
(Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology)
Wang, Hai-Feng (Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology) Wang, Jian-Song (Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology) Zhan, Hui (Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology) Zuo, Yi-Gang (Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology) Yang, De-Lin (Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology) Liu, Jing-Yu (Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology) Wang, Wei (Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology) Ke, Chang-Xing (Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology) Yan, Ru-Ping (Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology) |
1 | Banks DD (2011). The effect of glycosylation on the folding kinetics of erythropoietin. J Mol Biol, 412, 536-50. DOI |
2 | Boscher C, Dennis JW, Nabi IR (2011). Glycosylation, galectins and cellular signaling. Curr Opin Cell Biol, 23, 383-92. DOI |
3 | Brooks SA, Carter TM, Bennett EP, et al (2007). Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer. Acta Histochem, 109, 273-84. DOI |
4 | Gallagher DJ, Milowsky MI, Gerst SR, et al (2010). Phase II study of sunitinib in patients with metastatic urothelial cancer. J Clin Oncol, 28, 1373-79. DOI |
5 | Gao Y, Tu YB, Guo Y, et al (2011). PpGalNacT2 participating in vanadium-induced HL-60 cell differentiation. Mol Biol Rep, 38, 1483-9. DOI |
6 | Gerken TA, Jamison O, Perrine CL, et al (2011). Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases. J Biol Chem, 286, 14493-507. DOI |
7 | Kato K, Takeuchi H, Kanoh A, et al (2010). Loss of UDPGalNAc: polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis. Glycoconj J, 27, 267-76. DOI |
8 | Liu C, Lin D, Xu L, et al (2011). An anti-human ppGalNAcT-2 monoclonal antibody. Hybridoma (Larchmt), 30, 549-54. DOI ScienceOn |
9 | Perrine CL, Ganguli A, Wu P, et al (2009). Glycopeptidepreferring polypeptide GalNAc transferase 10 (ppGalNAcT10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2. J Biol Chem, 284, 20387-97. DOI |
10 | Platt FM, Hurst CD, Taylor CF, et al(2009). Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer. Clin Cancer Res, 15, 6008-17. DOI |
11 | Topaz O, Bergman R, Mandel U, et al(2005). Absence of intraepidermal glycosyltransferase ppGalNac-T3 expression in familial tumoral calcinosis. Am J Dermatopathol, 27, 211-5. DOI |
12 |
Tran DT, Lim JM, Liu M, et al (2012). Glycosylation of |
13 | Zlocowski N, Sendra VG, Lorenz V, et al (2011). Catalytic and glycan-binding abilities of ppGalNAc-T2 are regulated by acetylation. Biochem Biophys Res Commun, 410, 140-5. DOI |
![]() |